Researchers are developing an imaging method allowing surgeons to better ID cancerous cells in the breast tumor margins during surgery.
Category: Women’s Imaging
A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing. The discovery is an early step in finding new therapeutics for triple-negative breast cancer, one of the most difficult disease sub-types to treat.Read More
According to a new study, imaging surveillance is a management alternative for architectural distortion on digital breast tomosynthesis yielding radial scar without atypia and other concordant benign pathologies without atypia at biopsy.Read More
iCAD, Inc. announces that the company’s breast artificial intelligence platform was granted an Authorization to Operate from the U.S. Department of Defense.Read More
Researchers have developed an artificial intelligence platform to analyze potentially cancerous lesions in mammography scans to determine if a patient should receive an invasive biopsy. But unlike its many predecessors, the algorithm is interpretable, meaning it shows physicians exactly how it came to its conclusions.Read More